Our March 2020 edition is live!
Our March 2020 issue includes partnering companies focused on developing therapies for oncology.
Our first issue of the year covers companies focusing on new therapies for the treatment of oncology. The feature editorials cover recent oncology dealmaking trends and a review of the M&As that took place in 2019.
Read the full issue here